An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml
Not Applicable
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00002172
- Lead Sponsor
- The Immune Response Corporation
- Brief Summary
To provide product through an expanded access program to HIV-infected patients with CD4 counts less than 300 cells/ml.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Immune Response Corp
🇺🇸Carlsbad, California, United States
Immune Response Corp🇺🇸Carlsbad, California, United States